Skin-to-Skin Contact for Premature Birth
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how skin-to-skin contact with the mother affects premature babies compared to standard incubator care. Researchers aim to determine if this contact improves vital signs such as body temperature and heart rate, while also observing the babies' movements and emotions. They will compare babies receiving skin-to-skin contact immediately after birth with those receiving standard care in the neonatal intensive care unit. Preterm infants born 8 to 12 weeks early, who do not require immediate medical interventions, are suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to enhance understanding of the benefits of maternal contact for preterm infants.
Do I need to stop my current medications for the trial?
The trial information does not specify whether participants need to stop taking their current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that skin-to-skin contact, or "kangaroo care," is safe for premature babies. Studies have found that this method can strengthen the bond between mother and baby and improve the baby's brain development. It may also aid brain growth and reduce the risk of death in babies with low birth weight. These findings suggest that skin-to-skin contact is well-received and benefits both the baby and the mother.12345
Why are researchers excited about this trial?
Researchers are excited about skin-to-skin contact for premature birth because it offers a natural and immediate bonding experience that might enhance the baby's development and stability. Unlike the standard care, which involves transferring the baby to a neonatal intensive care unit, skin-to-skin contact allows the newborn to remain on the mother's chest for up to two hours. This method could improve the baby's heart rate, temperature regulation, and overall comfort by mimicking the warm, secure environment of the womb.
What evidence suggests that skin-to-skin contact might be an effective treatment for premature birth?
This trial will compare skin-to-skin contact, known as "kangaroo care," with standard care for premature babies. Research has shown that skin-to-skin contact can greatly benefit babies born early. Studies have found that this method can lead to better brain development by the time the baby reaches one year of age. For babies with low birth weight, kangaroo care is associated with a 36% lower risk of death compared to regular care. It also boosts the mother's confidence and reduces her risk of depression. Although some studies did not find long-term brain development improvements, evidence strongly supports the overall benefits for early survival and emotional well-being.23567
Who Is on the Research Team?
Håkon Bergseng, md phd
Principal Investigator
Norwegian University of Science and Technology
Are You a Good Fit for This Trial?
This trial is for preterm infants born between 28-32 weeks of gestation. It's not suitable for those needing immediate medical interventions after birth.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Preterm infants receive skin-to-skin contact with the mother or standard care in an incubator immediately after birth
Initial Follow-up
Infants are monitored for physiological and social/emotional responses, including video recording during the first 24 hours and at three months of age
Long-term Follow-up
Assessment of cognitive development, social/emotional competence, and other developmental skills at one and two years corrected age
What Are the Treatments Tested in This Trial?
Interventions
- skin-to-skin
- standard care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Norwegian University of Science and Technology
Lead Sponsor
Drammen sykehus
Collaborator
IWK Health Centre
Collaborator
Sorlandet Hospital HF
Collaborator
St. Olavs Hospital
Collaborator